510(k) device
Tomey Cornea/Anterior Segment OCT (CASIA2)
Tomey Corporation · Tomography, Optical Coherence (OBO, Class II) · First FDA decision Apr 27, 2022, newest Jul 18, 2025GlaucomaMacular degeneration and retinal disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
16
Naming "Cornea Anterior Segment"
MAUDE reports
0
Brand "Cornea Anterior Segment", since 2015
PubMed studies
21
Mentioning "Cornea Anterior Segment"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Tomey Cornea/Anterior Segment OCT (CASIA2)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K250553 · Decided Jul 18, 2025 · 143 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
K213265 · Decided Apr 27, 2022 · 209 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Cornea Anterior Segment", any status and sponsor, newest update first.
Duke UniversityAcademic, hospital or other
NCT03713268 · 262 participants (planned) · Start Sep 30, 2018 · Primary completion Dec 31, 2026
Device: Microscope integrated optical coherence tomography · For: Macular Holes; Epiretinal Membrane; Diabetic Retinopathy and 7 more
Sites: Durham, North Carolina
- Occyo Tele-ophthalmology StudyCompleted
Medical University InnsbruckAcademic, hospital or other
NCT06681350 · 365 participants · Start Oct 15, 2024 · Primary completion Jun 19, 2026
Device: Ocular surface imaging · For: Cataract
Sites: Innsbruck, Austria
- Clinical Study - ES 900 - 2020-2Completed
Haag-Streit AGNot on our public-company list
NCT04392349 · 29 participants · Start Jul 1, 2020 · Primary completion Aug 20, 2020
Device: Haag-Streit EYESTAR 900; Tomey CASIA 2 and 2 more · For: Cataract; Keratoconus
Sites: Basel, Switzerland
13 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cornea Anterior Segment", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OBO
13 reports: 4 malfunction, 9 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Cornea Anterior Segment"[tiab]. The summary above synthesizes these.
- Posterior microphthalmos with pigmentary retinopathy.
C Parameswarappa D, Dogra A · BMJ Case Rep · 2020Case Reports
- ISOPT Clinical Hot Topic Panel Discussion on Cornea Anterior Segment Disease.
Asbell PA, Aquavella JV, Hamrah P, et al. · J Ocul Pharmacol Ther · 2019Conference Proceedings
- Artificial intelligence and machine learning in ophthalmology: A review.
Srivastava O, Tennant M, Grewal P, et al. · Indian J Ophthalmol · 2023Review
- Ocular chemical injuries and their management.
Singh P, Tyagi M, Kumar Y, et al. · Oman J Ophthalmol · 2013Review
- A Datasheet for the INSIGHT Moorfields Cornea Anterior Segment Dataset (CADMUS).
Balal S, Alsafi Z, Leucci M, et al. · Ophthalmol Sci · 2026
- Ocular anterior segment changes in pregnancy.
Goldich Y, Cooper M, Barkana Y, et al. · J Cataract Refract Surg · 2014Comparative Study
- Automated Keratoconus Detection by 3D Corneal Images Reconstruction.
Mahmoud HAH, Mengash HA · Sensors (Basel) · 2021
- Iris fixation of posterior chamber intraocular lenses.
Zeh WG, Price FW · J Cataract Refract Surg · 2000Comparative Study, Research Support, Non-U.S. Gov't
- Metrics of the normal cornea: anterior segment imaging with the Visante OCT.
Sorbara L, Maram J, Fonn D, et al. · Clin Exp Optom · 2010Research Support, Non-U.S. Gov't
- Delayed diagnosis of glaucoma in Coffin-Siris syndrome.
Chen AC, Miller M, Kapamajian M, et al. · Am J Ophthalmol Case Rep · 2025Case Reports
- Racial Differences in Corneal Endothelial Cells in Adult Patients.
Ellsworth S, Chahal R, Phan V, et al. · Cornea · 2026
- Tear meniscus measurement by spectral optical coherence tomography.
Czajkowski G, Kaluzny BJ, Laudencka A, et al. · Optom Vis Sci · 2012Comparative Study
Other devices of this type
Also filed under product code OBO.
- SPECTRALIS HRA+OCT and variantsHeidelberg Engineering GmbH · 510(k) 2026
- CIRRUS HD-OCT Model 6000Carl Zeiss Meditec, Inc. · 510(k) 2024
- AnterionHeidelberg Engineering GmbH · 510(k) 2026
- Spectralis HRA + OCT and variantsHeidelberg Engineering GmbH · 510(k) 2018
- 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maestro2)Topcon Corporation · 510(k) 2024
- P200TE (A10700)Optos Plc. · 510(k) 2024
- RESCAN 700, CALLISTO eyeCarl Zeiss Meditec, AG · 510(k) 2019
- iVueOptovue, Inc. · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.